Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004521463 | SCV005022991 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-03-10 | criteria provided, single submitter | clinical testing | The p.P1408T variant (also known as c.4222C>A), located in coding exon 21 of the BLM gene, results from a C to A substitution at nucleotide position 4222. The proline at codon 1408 is replaced by threonine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV004759412 | SCV005368926 | uncertain significance | not provided | 2023-06-18 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |